Amani Therapeutics, Inc. — Form D
Amani Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2025-12-10. The offering totals $31.1M, of which $31.1M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2025-12-10
- Form: D
- Accession: 0002099941-25-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $31.1M
- Amount sold: $31.1M
- Investors: 2
- Date of first sale: 2025-11-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-566363
Issuer
- Name: Amani Therapeutics, Inc.
- CIK: 0002099941
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 40 10TH AVENUE, NEW YORK, NY, 10014
- Phone: (646) 597-6980
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Alice Lee | Director | New York, NY |
| Alice Lee | Executive Officer | New York, NY |
| -- RTW Holdings VI, LLC | Promoter | New York, NY |
More